Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000045

Chief Scientific Officer acquired 9,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Jewell Christopher M · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-10 Exercise or conversion : show line 1 in the form +9,000 $3.23 $29,070 62,490 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-10 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −9,000 67,432 D
Loading xslF345X05/wk-form4_1736802540.xml…